Skip to content

Clinical study on ultrasound-guided intra-articular injection combined with Baimai ointment mediated extracorporeal shock wave therapy for shoulder periarthritis

Clinical study on ultrasound-guided intra-articular injection combined with Baimai ointment mediated extracorporeal shock wave therapy for shoulder periarthritis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400086336
Enrollment
Unknown
Registered
2024-06-28
Start date
2024-07-15
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

shoulder periarthritis

Interventions

Ultrasound guided intra-articular injection :Ultrasound guided intra-articular injection of 1ml sodium hyaluronate injection, as well as 1ml compound betamethasone injection, 5ml 2% lidocaine injectio
Ultrasound guided intra-articular injection combined with extracorporeal shock wave treatment :Extracorporeal shockwave therapy before Ultrasound guided intra-articular injection
Ultrasound guided intra-articular injection combined with Baimai ointment mediated extracorporeal shock wave treatment :Extracorporeal shockwave therapy mediated by Baimai ointment before Ultrasound g

Sponsors

Zhuji Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: The patient who came to Zhuji Second People's Hospital for treatment was diagnosed with shoulder periarthritis.

Exclusion criteria

Exclusion criteria: ? X-ray, ultrasound or MR examination indicates shoulder joint fracture, dislocation, and rotator cuff tear; ? Shoulder joint trauma and surgical history; ? Have rheumatoid arthritis, tumor, tuberculosis or diabetes; ? Severe bleeding, coagulation dysfunction or psychological disorders.

Design outcomes

Primary

MeasureTime frame
visual analogue scale, VAS;

Secondary

MeasureTime frame
Constant-Murley score, CMS;

Countries

China

Contacts

Public ContactTiejun Jiang

Zhuji Second People's Hospital

tiejunjiang@163.com+86 135 6758 8060

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026